S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Prologis Stock Leading U.S. Logistics Boom
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Prologis Stock Leading U.S. Logistics Boom
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Prologis Stock Leading U.S. Logistics Boom
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Prologis Stock Leading U.S. Logistics Boom
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains

Aprea Therapeutics (APRE) SEC Filings & 10K Form

$5.73
-0.12 (-2.05%)
(As of 05:26 PM ET)

Recent Aprea Therapeutics SEC Filings

DateFilerForm TypeView
04/10/2024
3:15 PM
Aprea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
4:59 PM
Aprea Therapeutics (Issuer)
Hamill John P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
4:57 PM
Aprea Therapeutics (Issuer)
Gilad Oren (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
7:15 AM
Aprea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2024
6:45 AM
Aprea Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/14/2024
7:51 PM
Aprea Therapeutics (Issuer)
Gilad Oren (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
7:52 PM
Aprea Therapeutics (Issuer)
HENNEMAN JOHN B III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
7:53 PM
Aprea Therapeutics (Issuer)
Seizinger Bernd R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
7:54 PM
Aprea Therapeutics (Issuer)
Hamill John P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
3:31 PM
Aprea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
7:00 AM
Aprea Therapeutics (Subject)
Sio Capital Management, LLC (Filed by)
Form SC 13G
02/07/2024
5:55 PM
Aprea Therapeutics (Subject)
HIRSCHMAN ORIN (Filed by)
Form SC 13G/A
02/06/2024
4:01 PM
Aprea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2024
11:15 PM
Aprea Therapeutics (Filer)
Form EFFECT
01/26/2024
6:13 AM
Aprea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/26/2024
5:03 AM
Aprea Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/04/2024
3:16 PM
Aprea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
3:20 PM
Aprea Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
10/16/2023
4:29 PM
Aprea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/13/2023
6:31 AM
Aprea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2023
7:30 AM
Aprea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/24/2023
8:50 PM
Aprea Therapeutics (Issuer)
Peters Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2023
8:51 PM
Aprea Therapeutics (Issuer)
HENNEMAN JOHN B III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2023
8:51 PM
Aprea Therapeutics (Issuer)
Grissinger Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2023
8:52 PM
Aprea Therapeutics (Issuer)
Pamukcu Rifat (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2023
8:45 PM
Aprea Therapeutics (Issuer)
BIZZARI JEAN-PIERRE (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/24/2023
8:47 PM
Aprea Therapeutics (Issuer)
BIZZARI JEAN-PIERRE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2023
8:48 PM
Aprea Therapeutics (Issuer)
Seizinger Bernd R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2023
8:50 PM
Aprea Therapeutics (Issuer)
Duey Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2023
7:00 AM
Aprea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2023
6:36 AM
Aprea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2023
6:39 AM
Aprea Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/11/2023
6:40 AM
Aprea Therapeutics (Filer)
Form ARS
07/11/2023
6:30 AM
Aprea Therapeutics (Filer)
Form DEF 14A
06/08/2023
3:34 PM
Aprea Therapeutics (Issuer)
Seizinger Bernd R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2023
4:16 PM
Aprea Therapeutics (Issuer)
Gruia Gabriela (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/08/2023
4:17 PM
Aprea Therapeutics (Issuer)
Gruia Gabriela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2023
7:45 AM
Aprea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2023
3:15 PM
Aprea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:APRE) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners